Catalog No.S8405

RRx-001 Chemical Structure

Molecular Weight(MW): 268.02

RRx-001 is a novel epigenetic modulator with potential radiosensitizing activity. It inhibits glucose 6-phosphate dehydrogenase(G6PD) in human tumor cells, binds hemoglobin and drives RBC-mediated redox reactions under hypoxia.

Size Price Stock Quantity  
USD 147 In stock
USD 497 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective Dehydrogenase Inhibitors

Biological Activity

Description RRx-001 is a novel epigenetic modulator with potential radiosensitizing activity. It inhibits glucose 6-phosphate dehydrogenase(G6PD) in human tumor cells, binds hemoglobin and drives RBC-mediated redox reactions under hypoxia.
G6PD [1]
Nrf2-ARE [3]
In vitro

RRx-001 exerts its anti-proliferative effect, at least partially, through interference with glucose 6 phosphate dehydrogenase (G6PD), a key enzyme in the pentose phosphate pathway, responsible for maintaining adequate levels of the major cellular reductant, NADPH. RRx-001 affects glucose and G6PD enzyme activity in three different cancer cell lines namely Hep G2, CACO-2, and HT-29. RRx-001 induced G6PD inhibition and increased glucose consumption in a concentration dependent fashion. RRx-001 induces p53 and PARP-1 via generation of ROS/RNS. It exerts anticancer activity, at least in part, by interfering with 3 crucial metabolic demands of rapidly proliferating cells: bioenergetics, macromolecular biosynthesis, and manipulation of cellular cytosolic redox homeostasis[1]. RRx-001 mediates nuclear translocation of Nrf2 and the activation of expression of its downstream enzymes HO-1 and NQO1 in tumor cells. Apart from epigenetic alterations, RRx-001 acts via pleiotropic mechanisms including redox signaling and redox-induced dysregulation of many different signal pathways such as Nrf2, p53, PARP cleavage, HIF1 alpha, and G6PD activity. It also triggers p53 and p21 activity in response to double-stranded DNA breaks as well as deregulates cancer cellular energetics and metabolism. RRx-001 is a potent activator of the Nrf2-ARE signaling pathway via ROS/RNS generation[3].

In vivo RRx-001 shows promise for short-term blood flow redistribution in tumors with a pericyte- and α-SMA-rich vasculature[2]. RRx-001 monotherapy is well tolerated, with no dose-limiting toxicities. It not only facilitates nuclear translocation of Nrf2, but also upregulates endogenous Nrf2 expression in SCC VII tumors in mice[3].


Cell Research:[1]
+ Expand
  • Cell lines: Human cell cancer lines HEP-G2, HT-29 and CACO-2
  • Concentrations: 5, 50, and 100 μM
  • Incubation Time: up to 72 h
  • Method: Cell growth and proliferation is assessed using the MTT proliferation assay kit. Briefly, 5×103 cells are seeded in each well of a 96-well plate and cells are treated with or without compounds. Cells are cultured for up to 72 h. MTT reagent (10 μL) is added to each well, and then incubate for 3 h. Post incubation, the culture medium is removed, 100 μL Crystal Dissolving Solution is added to each well, and the absorbance of the solution is measured at 570 nm. MTT assays for samples of the same conditions are performed in triplicate. Briefly, MTT solution (0.5 mg/mL) is added, cells are incubated at 37ºC for 4 h and absorption at 540 nm is measured using a microplate reader.
    (Only for Reference)
Animal Research:[2]
+ Expand
  • Animal Models: C3H mice/SCID mice
  • Formulation: --
  • Dosages: 15 mg/kg
  • Administration: i.v.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 53 mg/mL (197.74 mM)
Ethanol 23 mg/mL (85.81 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 268.02


CAS No. 925206-65-1
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02215512 Active not recruiting Brain Metastases EpicentRx Inc. February 6 2015 Phase 1
NCT02801097 Recruiting Malignant Solid Tumor|Metastatic Cancer|Advanced Cancer EpicentRx Inc. August 30 2016 Phase 1
NCT02518958 Active not recruiting Malignant Solid Tumor|Lymphoma EpicentRx Inc. July 21 2015 Phase 1
NCT02489903 Recruiting Small Cell Carcinoma|Carcinoma Non-Small-Cell Lung|Neuroendocrine Tumors|Ovarian Epithelial Cancer EpicentRx Inc. June 2015 Phase 2
NCT02096354 Active not recruiting Colorectal Neoplasms EpicentRx Inc. May 2014 Phase 2
NCT02096341 Terminated Malignant Solid Tumor|Lymphomas EpicentRx Inc. April 2014 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Dehydrogenase Signaling Pathway Map

Related Dehydrogenase Products

Tags: buy RRx-001 | RRx-001 supplier | purchase RRx-001 | RRx-001 cost | RRx-001 manufacturer | order RRx-001 | RRx-001 distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID